Inhibition of Transporter-Mediated Hepatic Uptake as a Mechanism for Drug-Drug Interaction between Cerivastatin and Cyclosporin A
Data up to Jan 2025
Total Citations Per Year
Abstract
References (40)
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
1951 • 319,299 citations
A pharmacokinetic analysis program (multi) for microcomputer.
1981 • 2,465 citations
Pentoxifylline
1987 • 1,768 citations
Molecular Identification and Characterization of Novel Members of the Human Organic Anion Transporter (OATP) Family
2000 • 636 citations
A Novel Human Hepatic Organic Anion Transporting Polypeptide (OATP2)
1999 • 630 citations
A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane
2000 • 611 citations
Identification of a Novel Gene Family Encoding Human Liver-specific Organic Anion Transporter LST-1
1999 • 546 citations
Localization and Genomic Organization of a New Hepatocellular Organic Anion Transporting Polypeptide
2000 • 516 citations
Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver.
1998 • 497 citations
Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8.
1994 • 390 citations
Cryopreserved human hepatocytes: characterization of drug-metabolizing activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug–drug interaction potential
1999 • 295 citations
Mechanistic Studies on Metabolic Interactions between Gemfibrozil and Statins
2002 • 286 citations
Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood
1982 • 271 citations
Transcellular Transport of Organic Anions Across a Double-transfected Madin-Darby Canine Kidney II Cell Monolayer Expressing Both Human Organic Anion-transporting Polypeptide (OATP2/SLC21A6) and Multidrug Resistance-associated Protein 2 (MRP2/ABCC2)
2002 • 232 citations
Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes.
2001 • 211 citations
Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney
2002 • 176 citations
Clinical Pharmacokinetics of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors
1996 • 168 citations
A significant role of human cytochrome P450 2C8 in amiodarone N-deethylation: an approach to predict the contribution with relative activity factor.
2000 • 162 citations
Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients
1999 • 157 citations
Gemfibrozil
1988 • 145 citations
Clinical pharmacology of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors
1999 • 122 citations
Clinical Pharmacokinetics of Cerivastatin
2000 • 118 citations
Altered disposition of pravastatin following concomitant drug therapy with cyclosporin A in transplant recipients.
1993 • 113 citations
Isolation and culturing of hepatocytes from human livers
1992 • 113 citations
Comparative inhibitory effects of different compounds on rat oatpl (slc21a1)- and Oatp2 (Slc21a5)-mediated transport.
2002 • 108 citations
Prediction of in vivo interaction between triazolam and erythromycin based on in vitro studies using human liver microsomes and recombinant human CYP3A4.
2000 • 95 citations
The xenobiotic inhibitor profile of cytochrome P4502C8
2000 • 87 citations
Contribution of sodium taurocholate co-transporting polypeptide to the uptake of its possible substrates into rat hepatocytes.
1998 • 76 citations
Drug Transporters: Their Role and Importance in the Selection and Development of New Drugs
2002 • 74 citations
Carrier-mediated uptake of pravastatin by rat hepatocytes in primary culture
1992 • 65 citations
Exercise and diet reduce risk of diabetes, US study shows
2001 • 63 citations
Bayer decides to withdraw cholesterol lowering drug.
2001 • 57 citations
Influence of erythromycin pre- and co-treatment on single-dose pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin
1998 • 53 citations
Inhibition of biliary excretion of methotrexate by probenecid in rats: quantitative prediction of interaction from in vitro data.
2001 • 53 citations
Contribution of organic anion transporting polypeptide to uptake of its possible substrates into rat hepatocytes.
1999 • 50 citations
Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems.
2000 • 23 citations
Assignment<footref rid="foot01"><sup>1</sup></footref> of liver-specific organic anion transporter (SLC22A7) to human chromosome 6 bands p21.2→p21.1 using radiation hybrids
2000 • 14 citations
Carrier-Mediated Uptake of Cerivastatin in Primary Cultured Rat Hepatocytes.
2000 • 6 citations
QUANTITATIVE PREDICTION: METABOLISM, TRANSPORT IN THE LIVER
1999 • 2 citations
UK government launches anti-tobacco campaign for Asians
2001 • 2 citations